BioSpace News Archive

Today, the U.S. Food and Drug Administration is announcing that it considers vaporized hydrogen peroxide (VHP) to be an established method of sterilization for medical devices, recognizing VHP’s long history of safety and effectiveness.

NovelMed, a clinical-stage biopharmaceutical company with expertise in inflammatory and complement-related diseases, is pleased to announce that the United States Adopted Name (USAN) Council has officially assigned the generic name “Ruxoprubart” to its monoclonal antibody candidate, NM8074.

Yield10 Bioscience, Inc. today announced that the Company recently filed a request for a Regulatory Status Review (“RSR”) with USDA-APHIS Biotechnology Regulatory Services for proprietary elite Camelina sativa (“Camelina”) varieties designed to produce seed oil containing both essential omega-3 fatty acids eicosapentaenoic acid (“EPA”) and docosahexaenoic acid (“DHA”).

Veru Inc. today announced submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration for the development of enobosarm for obesity.

Neuronetics, Inc. today announced certain preliminary unaudited fourth quarter and full year 2023 results.

CorMedix Inc. announced several commercial and operational updates related to its business and anticipated launch of DefenCath®.

SI-BONE, Inc. announced its preliminary and unaudited revenue for fourth quarter and full year 2023.

Precigen, Inc. today released highlights of pipeline updates to be presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 at 5:15 PM PST in San Francisco, California.

Aditxt, Inc. today announces that the Company and its subsidiary, Pearsanta, Inc. (“Pearsanta”), has acquired MDNA Life Sciences Inc.’s (“MDNA”) proprietary, early disease and cancer detection platform.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. today announces that it has entered into an Exclusive Option and License Agreement with Radiance Biopharma Inc.